Utah Medical Products (UTMD) Research & Development (2010 - 2026)

Utah Medical Products has reported Research & Development for 17 years, with the latest figure at $154000.0 in Q2 2026.

• On a quarterly basis, Research & Development rose 14.07% year-over-year to $154000.0 in Q2 2026; TTM through Jun 2026 was $2.1 million, a 23.95% increase from a year earlier, with the FY2025 full-year figure at $2.1 million, up 7.89% from the prior year.
• Research & Development was $154000.0 for Q2 2026 at Utah Medical Products, roughly flat from $154000.0 in the prior quarter.
• The five-year high for Research & Development was $1.6 million in Q4 2025, with the low at $112000.0 in Q3 2022.
• Average Research & Development over 5 years is $414111.1, with a median of $154000.0 recorded in 2025.
• The sharpest annual moves came in 2024 and 2025: Research & Development soared 91.73% in 2024, then sank 47.06% in 2025.
• Over 5 years, Research & Development stood at $1.1 million in 2022, then advanced by 11.79% to $1.3 million in 2023, then retreated by 4.88% to $1.2 million in 2024, then surged by 31.93% to $1.6 million in 2025, then plunged by 90.34% to $154000.0 in 2026.
• The last three Research & Development figures came in at $154000.0 (Q2 2026), $154000.0 (Q1 2026), and $1.6 million (Q4 2025), per Business Quant data.